| Rita Kay Acebo, DPM | |
|
3692 E Sam Houston Pkwy S Ste 100, Pasadena, TX 77505-3136 | |
| (713) 946-1500 | |
| (713) 946-0200 |
| Full Name | Rita Kay Acebo |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 5 Years |
| Location | 3692 E Sam Houston Pkwy S Ste 100, Pasadena, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942868161 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | T24-2019 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mckinney Podiatric Associates Pa | 3072540731 | 7 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has filed a New Drug Application (NDA) in Japan to seek regulatory approval for intravenous (i.v.) peramivir to treat patients with influenza. As a consequence of this filing, BioCryst will receive a regulatory milestone payment of $7 million under its agreement with Shionogi.
Gastrointestinal (GI ) symptoms are proven to be more common in patients undergoing peritoneal dialysis than in patients with chronic renal failure having hemodialysis. However, whether the onset of these GI symptoms is related to the chronic renal failure itself, its treatment, or alternatively, other factors, is still unknown
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 329-348(20); DOI: https://doi.org/10.15212/CVIA.2017.0068 Sonia Henry, MD, Rachel Bond, MD, Stacey Rosen, MD, Cindy Grines, MD and Jennifer Mieres, MD from the Hofstra School of Medicine, Manhasset, NY, USA, Lenox Hill Hospital, New York, NY, USA and The Katz Institute for Women's Health, Lake Success, NY, USA consider the challenges in cardiovascular risk prediction and stratification in women.
HMS today announced that it has acquired the assets of Verify Solutions, a metropolitan Atlanta-based company specializing in dependent eligibility audit services for employer-sponsored healthcare plans.
A majority of people in the United States say they want ObamaCare to be scaled back or repealed altogether. According to a Gallup poll released Friday, 20 percent support a scale-back of the law, while 32 percent back efforts to repeal it (Shabad, 12/6).
› Verified 3 days ago
| Provider Name | Mckinney Podiatric Associates Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1538194394 PECOS PAC ID: 3072540731 Enrollment ID: O20050725000524 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has filed a New Drug Application (NDA) in Japan to seek regulatory approval for intravenous (i.v.) peramivir to treat patients with influenza. As a consequence of this filing, BioCryst will receive a regulatory milestone payment of $7 million under its agreement with Shionogi.
Gastrointestinal (GI ) symptoms are proven to be more common in patients undergoing peritoneal dialysis than in patients with chronic renal failure having hemodialysis. However, whether the onset of these GI symptoms is related to the chronic renal failure itself, its treatment, or alternatively, other factors, is still unknown
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 329-348(20); DOI: https://doi.org/10.15212/CVIA.2017.0068 Sonia Henry, MD, Rachel Bond, MD, Stacey Rosen, MD, Cindy Grines, MD and Jennifer Mieres, MD from the Hofstra School of Medicine, Manhasset, NY, USA, Lenox Hill Hospital, New York, NY, USA and The Katz Institute for Women's Health, Lake Success, NY, USA consider the challenges in cardiovascular risk prediction and stratification in women.
HMS today announced that it has acquired the assets of Verify Solutions, a metropolitan Atlanta-based company specializing in dependent eligibility audit services for employer-sponsored healthcare plans.
A majority of people in the United States say they want ObamaCare to be scaled back or repealed altogether. According to a Gallup poll released Friday, 20 percent support a scale-back of the law, while 32 percent back efforts to repeal it (Shabad, 12/6).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rita Kay Acebo, DPM 3692 E Sam Houston Pkwy S Ste 100, Pasadena, TX 77505-3136 Ph: (713) 946-1500 | Rita Kay Acebo, DPM 3692 E Sam Houston Pkwy S Ste 100, Pasadena, TX 77505-3136 Ph: (713) 946-1500 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has filed a New Drug Application (NDA) in Japan to seek regulatory approval for intravenous (i.v.) peramivir to treat patients with influenza. As a consequence of this filing, BioCryst will receive a regulatory milestone payment of $7 million under its agreement with Shionogi.
Gastrointestinal (GI ) symptoms are proven to be more common in patients undergoing peritoneal dialysis than in patients with chronic renal failure having hemodialysis. However, whether the onset of these GI symptoms is related to the chronic renal failure itself, its treatment, or alternatively, other factors, is still unknown
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 329-348(20); DOI: https://doi.org/10.15212/CVIA.2017.0068 Sonia Henry, MD, Rachel Bond, MD, Stacey Rosen, MD, Cindy Grines, MD and Jennifer Mieres, MD from the Hofstra School of Medicine, Manhasset, NY, USA, Lenox Hill Hospital, New York, NY, USA and The Katz Institute for Women's Health, Lake Success, NY, USA consider the challenges in cardiovascular risk prediction and stratification in women.
HMS today announced that it has acquired the assets of Verify Solutions, a metropolitan Atlanta-based company specializing in dependent eligibility audit services for employer-sponsored healthcare plans.
A majority of people in the United States say they want ObamaCare to be scaled back or repealed altogether. According to a Gallup poll released Friday, 20 percent support a scale-back of the law, while 32 percent back efforts to repeal it (Shabad, 12/6).
› Verified 3 days ago
Dr. Scott W Mckinney, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3692 E Sam Houston Pkwy S, Suite 100, Pasadena, TX 77505 Phone: 713-946-1500 Fax: 713-946-0200 | |
Francisco J Cuza, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3692 E Sam Houston Pkwy S, Suite 100, Pasadena, TX 77505 Phone: 713-946-1500 Fax: 713-946-0200 | |
Dr. Edward M. Jacquet Iii, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 5119 Fairmont Parkway, Suite B-2, Pasadena, TX 77505 Phone: 713-910-5577 Fax: 713-910-1992 | |
Texas Mobile Foot Consultants, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3222 Burke Rd, Suite 102, Pasadena, TX 77504 Phone: 713-948-0400 Fax: 713-948-0401 | |
Dr. Jorge L Cuza, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3692 E Sam Houston Pkwy S, Suite 100, Pasadena, TX 77505 Phone: 713-946-1500 Fax: 713-946-0200 | |
Fein Foot And Ankle Center Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 6243 Fairmont Pkwy Ste 203c, Pasadena, TX 77505 Phone: 832-301-9871 Fax: 281-630-2954 | |
Bruce Miller, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6021 Fairmont Pkwy, Ste 130, Pasadena, TX 77505 Phone: 281-991-0600 Fax: 281-991-0638 |